Plasma Cystatin C and Acute Kidney Injury after Cardiopulmonary Bypass
Authors:
Open Access
- 1 August 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 5 (8) , 1373-1379
Abstract
Background and objectives: Little is known about the performance of plasma cystatin C (CysC) in patients undergoing cardiopulmonary bypass (CPB) and its utility in the early diagnosis of acute kidney injury (AKI). In this post hoc analysis, the goal was to determine whether plasma cystatin C, measured 2 hours after the conclusion of CPB, is a reliable marker of AKI. Design, setting, participants, & measurements: Plasma CysC was measured in 150 patients undergoing CPB at the following times: preoperatively, 2 hours after the conclusion of CPB, postoperative day 1, and postoperative day 2. Plasma CysC levels were related to the development of AKI as defined by an increase in serum creatinine of ≥50% or ≥0.3 mg/dl from baseline up to 3 days postoperative. Mixed linear models were used to evaluate the relationship of serial plasma CysC values with AKI. The discriminatory capacity of plasma CysC was estimated using receiver operating characteristic curves. Logistic regression was utilized to assess the adjusted relationship between plasma CysC and subsequent AKI. Results: AKI developed in 47 (31.3%) patients. Plasma CysC was higher at all times among patients who developed AKI compared with those who did not (P < 0.0001). The discriminatory capacity of plasma CysC measured preoperatively and 2 hours after the conclusion of CPB was modest. Conclusions: Serial measures of plasma CysC are highly correlated with the development of AKI. However, the discriminatory capacity of plasma CysC as an early marker of AKI remains limited.Keywords
This publication has 27 references indexed in Scilit:
- Novel Biomarkers Early Predict the Severity of Acute Kidney Injury After Cardiac Surgery in AdultsThe Annals of Thoracic Surgery, 2009
- Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgeryThe Lancet, 2005
- Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patientsCritical Care, 2005
- Evolution and predictive power of serum cystatin C in acute renal failureClinical Nephrology, 2004
- Early detection of acute renal failure by serum cystatin CKidney International, 2004
- Minimal Changes of Serum Creatinine Predict Prognosis in Patients after Cardiothoracic SurgeryJournal of the American Society of Nephrology, 2004
- Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurementKidney International, 2004
- The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgeryThe Annals of Thoracic Surgery, 2003
- Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysisAmerican Journal of Kidney Diseases, 2002
- Pathophysiology of protracted acute renal failure in man.Journal of Clinical Investigation, 1985